688056 莱伯泰科
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)4.0144.6973.2895.5339.095
总资产报酬率 ROA (%)3.4903.9942.8044.8147.956
投入资产回报率 ROIC (%)3.7674.3153.0375.1938.561

边际利润分析
销售毛利率 (%)45.80145.54143.79147.70948.437
营业利润率 (%)12.86810.3176.84314.44720.870
息税前利润/营业总收入 (%)11.9469.5576.05613.76921.905
净利润/营业总收入 (%)11.4259.2336.62612.57018.818

收益指标分析
经营活动净收益/利润总额(%)78.383101.67895.04991.00884.529
价值变动净收益/利润总额(%)9.53011.10112.89410.2989.130
营业外收支净额/利润总额(%)-0.021-0.024-0.108-0.1846.020

偿债能力分析
流动比率 (X)7.2125.7425.3775.9587.255
速动比率 (X)5.5074.4674.2424.7606.263
资产负债率 (%)11.55214.45215.44814.02511.882
带息债务/全部投入资本 (%)4.1367.1597.8466.1935.007
股东权益/带息债务 (%)2,308.0241,289.7511,165.1681,506.3601,886.710
股东权益/负债合计 (%)765.615591.925547.333613.024741.585
利息保障倍数 (X)-12.999-12.615-7.775-21.166-72.601

营运能力分析
应收账款周转天数 (天)50.41045.81545.23448.08940.702
存货周转天数 (天)300.575264.144249.917249.236177.735